| Product Name | MF | CAS | Details |
|---|
| Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (cudarolimab) | Details |
| Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (ivuxolimab) | Details |
| Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (revdofilimab) | Details |
| Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (tavolixizumab) | Details |
| Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (telazorlimab) | Details |
| Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (vonlerizumab) | Details |
| Anti-TNFRSF5 / CD40 Reference Antibody (bleselumab) | Details |
| Anti-TNFRSF5 / CD40 Reference Antibody (dacetuzumab) | Details |
| Anti-TNFRSF5 / CD40 Reference Antibody (Emory U. anti-CD40) | Details |
| Anti-TNFRSF5 / CD40 Reference Antibody (giloralimab) | Details |
| Anti-TNFRSF5 / CD40 Reference Antibody (iscalimab) | Details |
| Anti-TNFRSF5 / CD40 Reference Antibody (lucatumumab) | Details |
| Anti-TNFRSF5 / CD40 Reference Antibody (mitazalimab) | Details |
| Anti-TNFRSF5 / CD40 Reference Antibody (ravagalimab) | Details |
| Anti-TNFRSF5 / CD40 Reference Antibody (selicrelumab) | Details |
| Anti-TNFRSF5 / CD40 Reference Antibody (sotigalimab) | Details |
| Anti-TIGIT Reference Antibody (vibostolimab) | Details |
| Anti-TIM-3 / HAVCR2 / CD366 Reference Antibody (cobolimab) | Details |
| Anti-TIM-3 / HAVCR2 / CD366 Reference Antibody (sabatolimab) | Details |
| Anti-Tissue factor / CD142 Reference Antibody (Chugai patent anti-TF) | Details |
| Anti-Tissue factor / CD142 Reference Antibody (tisotumab) | Details |
| Anti-Tissue factor / CD142 Reference Antibody (TNX-832) | Details |
| Anti-TLR2 / CD282 Reference Antibody (tomaralimab) | Details |
| Anti-TLR3 / CD283 Reference Antibody (CNTO5429) | Details |
| Anti-TLR7 Reference Antibody (U.Tokyo patent anti-TLR7) | Details |
| Anti-TMEFF1 / Tomoregulin-1 Reference Antibody (Bluefin patent anti-TMEFF1) | Details |
| Anti-TMEFF2 Reference Antibody (Janssen patent anti-TMEFF2) | Details |
| Anti-TMPRSS2 Reference Antibody (Regeneron patent anti-TMPRSS2 ) | Details |
| Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody (mapatumumab) | Details |
| Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (benufutamab) | Details |
| Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (conatumumab) | Details |
| Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (drozitumab) | Details |
| Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (lexatumumab) | Details |
| Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tigatuzumab) | Details |
| Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tilogotamab) | Details |
| Anti-TNFRSF12A / TWEAKR / CD266 Reference Antibody (enavatuzumab) | Details |
| Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab) | Details |
| Anti-TNFRSF17 / BCMA / CD269 Reference Antibody (belantamab) | Details |
| Anti-TNFRSF18 / GITR / CD357 Reference Antibody (Korea Natl.Cancer Ctr. patent anti-GITR) | Details |
| Anti-TNFRSF18 / GITR / CD357 Reference Antibody (ragifilimab) | Details |
| Anti-TNFRSF21 / DR6 / CD358 Reference Antibody (Abbvie patent anti-TNFRSF21) | Details |
| Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (BMS-986178) | Details |
| Anti-SLC2A8 Reference Antibody (VB1-050) | Details |
| Anti-SLC34A2 Reference Antibody (lifastuzumAb) | Details |
| Anti-SLC34A2 Reference Antibody (upifitamab) | Details |
| Anti-SLC40A1 Reference Antibody (Amgen patent anti-Ferroportin) | Details |
| Anti-SLC40A1 Reference Antibody (LY2928057) | Details |
| Anti-SLC44A4 Reference Antibody (ASG-5ME) | Details |
| Anti-SLITRK6 Reference Antibody (sirtratumab) | Details |
| Anti-Sortilin / SORT1 Reference Antibody (latozinemab) | Details |
| Anti-SOST / Sclerostin Reference Antibody (blosozumab) | Details |
| Anti-SOST / Sclerostin Reference Antibody (romosozumab) | Details |
| Anti-SOST / Sclerostin Reference Antibody (setrusumab) | Details |
| Anti-Sphingosine-1-phosphate Reference Antibody (Expression DD patent anti-SIP) | Details |
| Anti-Sphingosine-1-phosphate Reference Antibody (sonepcizumab) | Details |
| Anti-Spike RBD (Omicron / B.1.1.529) Antibody (P26130) | Details |
| Anti-Spike RBD (Omicron BA.2 / BA.2.75) Antibody (dAb-708) | Details |
| Anti-Spike RBD Antibody (P16-A3) | Details |
| Anti-Spike RBD Antibody (P17-A11) | Details |
| Anti-Spike RBD Antibody (P20-B4) | Details |
| Anti-Spike RBD Antibody (R14-F8) | Details |
| Anti-Spike RBD Antibody (R15-F7) | Details |
| Anti-Spike RBD Antibody (R16-F10) | Details |
| Anti-Spike RBD Antibody (RP1-E4) | Details |
| Anti-Spike RBD Antibody (RP1-H5) | Details |
| Anti-Spike RBD Antibody (RP6-E2) | Details |
| Anti-Spike RBD Antibody (RP6-E3) | Details |
| Anti-Spike S1 (Omicron BA.2 / BA.2.75 / BA.4 / BA.5) Antibody (THS-699) | Details |
| Anti-Spike S1 Antibody (NCOV-S1P14-Fc) | Details |
| Anti-Spike S1 Reference Antibody (CR3022) | Details |
| Anti-STAB1 Reference Antibody (bexmarilimab) | Details |
| Anti-TEM1 / Endosialin / CD248 Reference Antibody (ontuxizumab) | Details |
| Anti-TFPI Reference Antibody (marstacimab) | Details |
| Anti-Tau Reference Antibody (bepranemab) | Details |
| Anti-TBFbR2 Reference Antibody (LY3022859) | Details |
| Anti-TIE2 / CD202b Reference Antibody (Regeneron patent anti-TIE-2) | Details |
| Anti-STOP1 Reference Antibody (Genentech patent anti-STOP-1) | Details |
| Anti-TFPI Reference Antibody (concizumab) | Details |
| Anti-TGFb1 Reference Antibody (NIS793) | Details |
| Anti-TEM7R / PLXDC2 Reference Antibody (Fox Chase patent anti-TEM7R) | Details |
| Anti-TGFb1 Reference Antibody (fresolimumab) | Details |
| Anti-Tau Reference Antibody (gosuranemab) | Details |
| Anti-TCR Reference Antibody (NKTT320) | Details |
| Anti-TIGIT Reference Antibody (domvanalimab) | Details |
| Anti-Syndecan-1 / CD138 Reference Antibody (indatuximab) | Details |
| Anti-Tau Reference Antibody (tilavonemab) | Details |
| Anti-TGFb1 Reference Antibody (SRK181) | Details |
| Anti-TIGIT Reference Antibody (ociperlimab) | Details |
| Anti-Tenascin C Reference Antibody (tenatumomab) | Details |
| Anti-TGFb1 Reference Antibody (Genzyme patent anti-TGF-β) | Details |
| Anti-Tau Reference Antibody (semorinemab) | Details |
| Anti-TCR Reference Antibody (TOL101) | Details |
| Anti-TIGIT Reference Antibody (etigilimab) | Details |
| Anti-TAT226 Reference Antibody (Genentech patent anti-TAT226) | Details |
| Anti-Tau Reference Antibody (zagotenemab) | Details |
| Anti-TGM2 / Transglutaminase 2 Reference Antibody (zampilimab) | Details |
| Anti-TIGIT Reference Antibody (tiragolumab) | Details |
| Anti-STEAP1 Reference Antibody (vandortuzumAb) | Details |
| Anti-TFPI Reference Antibody (befovacimab) | Details |
| Anti-TGFb1 Reference Antibody (M7824) | Details |
| Product Total： Product Page： | ||||
| 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 | ||||